A phase 2 trial of Memo…
A phase 2 trial of Memo Therapeutics’ kidney transplant drug [...]
Ikena and Inmagene have selected…
Ikena and Inmagene have selected Kristin Yarema, Ph.D., to lead [...]
In this episode of “The Top Line,”…
In this episode of “The Top Line,” we dive into [...]
Although Sarepta Therapeutics…
Although Sarepta Therapeutics managed to defuse a brief stalemate with [...]
Eli Lilly is walking through the…
Eli Lilly is walking through the Gate, inking a deal [...]
Australian life sciences venture…
Australian life sciences venture capital firm Brandon Capital has closed [...]
Novartis is serving up $60 million…
Novartis is serving up $60 million to partner with Matchpoint [...]
A soon-to-be-released documentary…
A soon-to-be-released documentary aims to change the conversation around hemophilia, [...]
A direct-to-consumer program for…
A direct-to-consumer program for its drugs could bring down higher [...]
After ditching a plan to split…
After ditching a plan to split into two distinct companies, [...]